Fenbendazole and Ivermectin in Cancer Care: What the Research Actually Shows

A clinical nutritionist's review of mechanisms — including p53 reactivation, microtubule disruption, glycolysis inhibition, and immune synergy — for two of the most-discussed repurposed antiparasitics in integrative oncology.

Researched and written by Keith Bishop, Integrative Cancer Educator, Cancer Coach, Clinical Nutritionist, Retired Pharmacist, and Founder of Prevail Over Cancer.

You've heard the names. A friend mentioned them. A YouTube video swore by them. A Facebook group of 100,000 members says they cured stage IV cancer. And your oncologist either rolled their eyes or warned you against them.

So what is actually true about fenbendazole and ivermectin in cancer care?

After three decades as a pharmacist and now as a clinical nutritionist and cancer coach working with patients every day, I want to walk you through what the published research actually shows — the mechanisms, the preclinical data, th...